SEC Form D · Amendment · filed October 26, 2020
A2 Biotherapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Srini Akkaraju · Agoura Hills, CADirectorMadhavan Balachandran · Agoura Hills, CADirectorJakob S. Loven · Agoura Hills, CADirectorScott Foraker · Agoura Hills, CAExec · DirectorDavid Goeddel · Agoura Hills, CADirectorMichael Gallo · Agoura Hills, CADirectorC. A. Kamb · Agoura Hills, CADirectorHelen S. Kim · Agoura Hills, CADirectorHouman Ashrafian · London, United KingdomDirectorJason Zhang · Stamford, CTDirectorLaurence Barker · London, United KingdomDirectorJonathan Behr · London, United KingdomExec · DirectorCroatan All-Weather Fund II Advisers, LLC · VIRGINIA BEACH, VADirectorCroatan Investment Management LLC · VIRGINIA BEACH, VADirectorKate Bingham · London, United KingdomDirectorRalph Achacoso · Stamford, CTDirectorJames Gibson · Excelsior, MNExec · DirectorJohn Menzies · Austin, TXDirectorKevin Puil · Austin, TXDirectorJonathon Gay · BOSTON, MADirectorDaniel Gay · BOSTON, MADirectorPaul Vroomen · Santa Clara, CADirectorDaniel Armbrust · Santa Clara, CADirectorJohn Provine · Santa Clara, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗